Non-invasive diagnosis of advanced fibrosis and cirrhosis

Liver cirrhosis is a common and growing public health problem globally.The diagnosis of cirrhosis portends an increased risk of morbidity and mortality.Liver biopsy is considered the gold standard for diagnosis of cirrhosis and staging of fibrosis.However,despite its universal use,liver biopsy is an...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 20; no. 45; pp. 16820 - 16830
Main Author Sharma, Suraj
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 07.12.2014
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
2219-2840
DOI10.3748/wjg.v20.i45.16820

Cover

Loading…
More Information
Summary:Liver cirrhosis is a common and growing public health problem globally.The diagnosis of cirrhosis portends an increased risk of morbidity and mortality.Liver biopsy is considered the gold standard for diagnosis of cirrhosis and staging of fibrosis.However,despite its universal use,liver biopsy is an invasive and inaccurate gold standard with numerous drawbacks.In order to overcome the limitations of liver biopsy,a number of non-invasive techniques have been investigated for the assessment of cirrhosis.This review will focus on currently available non-invasive markers of cirrhosis.The evidence behind the use of these markers will be highlighted,along with an assessment of diagnostic accuracy and performance characteristics of each test.Non-invasive markers of cirrhosis can be radiologic or serum-based.Radiologic techniques based on ultrasound,magnetic resonance imaging and elastography have been used to assess liver fibrosis.Serum-based biomarkers of cirrhosis have also been developed.These are broadly classified into indirect and direct markers.Indirect biomarkers reflect liver function,which may decline with the onset of cirrhosis.Direct biomarkers,reflect extracellular matrix turnover,and include molecules involved in hepatic fibrogenesis.On the whole,radiologic and serum markers of fibrosis correlate well with biopsy scores,especially when excluding cirrhosis or excluding fibrosis.This feature is certainly clinically useful,and avoids liver biopsy in many cases.
Bibliography:Suraj Sharma;Korosh Khalili;Geoffrey Christopher Nguyen;Toronto Centre for Liver Disease, Toronto Western Hospital;Department of Medical Imaging, University Health Network;Joseph and Wolf Lebovic Health Complex, Mount Sinai Hospital
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Author contributions: Sharma S, Khalili K and Nguyen GC contributed to the research and drafting of the manuscript, and editing to its current form.
Correspondence to: Geoffrey Christopher Nguyen, MD, PhD, FRCPC, Joseph and Wolf Lebovic Health Complex, Mount Sinai Hospital, 437-600 University Avenue, Toronto, ON M5G 1X5, Canada. geoff.nguyen@utoronto.ca
Telephone: +1-416-5864800 Fax: +1-416-5865971
ISSN:1007-9327
2219-2840
2219-2840
DOI:10.3748/wjg.v20.i45.16820